The low incidence of CFU-F significantly complicates the isolation of homogeneous populations of mouse bone marrow stromal cells (BMSCs), a common problem being contamination with hematopoietic cells. Taking advantage of burgeoning evidence demonstrating the perivascular location of stromal cell stem/ progenitors, we hypothesized that a potential reason for the low yield of mouse BMSCs is the flushing of the marrow used to remove single-cell suspensions and the consequent destruction of the marrow vasculature, which may adversely affect recovery of BMSCs physically associated with the abluminal surface of blood vessels. Herein, we describe a simple methodology based on preparation and enzymatic disaggregation of intact marrow plugs, which yields distinct populations of both stromal and endothelial cells. The recovery of CFU-F obtained by pooling the product of each digestion (1631.8 ؉ 199) reproducibly exceeds that obtained using the standard BM flushing technique (14.32 ؉ 1.9) by at least 2 orders of magnitude (P < .001; N ؍ 8) with an accompanying 113.95-fold enrichment of CFU-F frequency when plated at low oxygen (5%). Purified BMSC populations devoid of hematopoietic contamination are readily obtained by FACS at P0 and from freshly prepared single-cell suspensions. Furthermore, this population demonstrates robust multilineage differentiation using standard in vivo and in vitro bioassays. (Blood. 2012;119(11):e86-e95)
IntroductionWithin adult bone marrow, nonhematopoietic stromal cells (bone marrow stromal cells [BMSCs]) are known to contain a subpopulation of multipotent progenitor cells variously referred to as "skeletal" or "mesenchymal" stem cells. [1][2][3][4][5][6] The differentiation potential of BMSCs and their capacity to contribute to tissue repair and regeneration, coupled with their unique immunosuppressive properties, have engendered considerable interest in the application of these cells to a rapidly burgeoning range of cellular therapies. [7][8][9][10][11] Originally identified in the BM of rodents by Friedenstein et al, 12 BMSCs have subsequently been isolated from many mammalian species, including human, rat, rhesus monkeys, dog, and pig through their preferential attachment to tissue culture plastic. [13][14][15][16][17] Although the majority of published reports are based on studies using human BMSCs, it is notable that relatively few publications focus specifically on BMSCs derived from mouse BM. This has hindered progress not only in addressing fundamental questions regarding BMSCs biology through the use of genetic mouse models but also the preclinical testing of proposed therapeutic applications of BMSCs in the mouse.Murine BMSCs have so far proven much more difficult to isolate from BM and to expand ex vivo than their counterparts from human BM. 18-21 CFU-F are a rare population in the marrow of all mammalian species so far examined, but this is particularly so in the case of the mouse. Reported incidences of CFU-F are typically in the range of 0.3 to 2 per 1 000 000 13,18,22 BM cell...